Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


11.12.2017

2 Antimicrob Agents Chemother
1 Chest
1 Eur Respir J
1 Infect Immun
1 J Clin Microbiol
1 Lancet Infect Dis
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. SARATHY JP, Via LE, Weiner D, Blanc L, et al
    Extreme drug tolerance of Mycobacterium tuberculosis in caseum.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02266.
    PubMed     Text format     Abstract available

  2. LEE H, Ahn S, Hwang NY, Jeon K, et al
    Limited Effect of Later-generation Fluoroquinolones in the Treatment of Ofloxacin-resistant and Moxifloxacin-susceptible Multidrug-resistant Tuberculosis.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.01784.
    PubMed     Text format     Abstract available


    Chest

  3. FIELD SK, Escalante P, Fisher DA, Ireland B, et al
    Cough Due to Tuberculosis and Other Chronic Infections: CHEST Guideline and Expert Panel Report.
    Chest. 2017 Nov 28. pii: S0012-3692(17)33131-8. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


    Eur Respir J

  4. CHE Y, Song Q, Yang T, Ping G, et al
    Fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis independent of fluoroquinolone use.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    Infect Immun

  5. LADDY DJ, Bonavia A, Hanekom WA, Kaushal D, et al
    Toward Tuberculosis Vaccine Development: Recommendations for NHP Study Design.
    Infect Immun. 2017 Dec 4. pii: IAI.00776-17. doi: 10.1128/IAI.00776.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  6. HAVLICEK J, Dachsel B, Slickers P, Andres S, et al
    Rapid Microarray-based Detection of Rifampicin-, Isoniazid- and Fluoroquinolone Resistance in Mycobacterium tuberculosis using a Single Cartridge.
    J Clin Microbiol. 2017 Dec 6. pii: JCM.01249-17. doi: 10.1128/JCM.01249.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  7. DORMAN SE, Schumacher SG, Alland D, Nabeta P, et al
    Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
    Lancet Infect Dis. 2017 Nov 30. pii: S1473-3099(17)30691.
    PubMed     Text format     Abstract available


    PLoS One

  8. LATORRE I, Minguez S, Carrascosa JM, Naves J, et al
    Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.
    PLoS One. 2017;12:e0189202.
    PubMed     Text format     Abstract available

  9. MAVE V, Kinikar A, Kagal A, Nimkar S, et al
    Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.
    PLoS One. 2017;12:e0189101.
    PubMed     Text format     Abstract available

  10. LAVANIA S, Anthwal D, Bhalla M, Singh N, et al
    Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears.
    PLoS One. 2017;12:e0189149.
    PubMed     Text format     Abstract available

  11. FLICK RJ, Munthali A, Simon K, Hosseinipour M, et al
    Assessing infection control practices to protect health care workers and patients in Malawi from nosocomial transmission of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0189140.
    PubMed     Text format     Abstract available

  12. KIMUDA SG, Andia-Biraro I, Egesa M, Bagaya BS, et al
    Use of QuantiFERON(R)-TB Gold in-tube culture supernatants for measurement of antibody responses.
    PLoS One. 2017;12:e0188396.
    PubMed     Text format     Abstract available

  13. JONSSON J, Westman A, Bruchfeld J, Sturegard E, et al
    A borderline range for Quantiferon Gold In-Tube results.
    PLoS One. 2017;12:e0187313.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: